Effects of different anti-diabetic pharmacotherapies on adipokine serum concentrations.

Comparison of adipokine serum concentrations in patients treated with or without metformin in monotherapy or in combination with GLP-1 analogues and insulin, as well as insulin monotherapy. Only significant differences between the different treatment regimens are displayed. Treatment with sulfonylurea, pioglitazone or DPP-4 inhibitors did not significantly affect serum adipokine concentrations.